These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 32347537)

  • 1. Chemotherapy-induced peripheral neuropathy-part 2: focus on the prevention of oxaliplatin-induced neurotoxicity.
    Sałat K
    Pharmacol Rep; 2020 Jun; 72(3):508-527. PubMed ID: 32347537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-induced peripheral neuropathy: part 1-current state of knowledge and perspectives for pharmacotherapy.
    Sałat K
    Pharmacol Rep; 2020 Jun; 72(3):486-507. PubMed ID: 32394362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine Stress Axis-Dependence of Duloxetine Analgesia (Anti-Hyperalgesia) in Chemotherapy-Induced Peripheral Neuropathy.
    Staurengo-Ferrari L; Bonet IJM; Araldi D; Green PG; Levine JD
    J Neurosci; 2022 Jan; 42(3):405-415. PubMed ID: 34880120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism-based Pharmacological Management of Chemotherapy-induced Neuropathic Pain from Preclinical Studies to Clinical Prospective: Platinum-based Drugs, Taxanes, and Vinca Alkaloids.
    Zafari N; Velayati M; Maftooh M; Khazaei M; Nassiri M; Hassanian SM; Ghayour-Mobarhan M; Ferns GA; Avan A
    Curr Pharm Des; 2023; 29(16):1245-1265. PubMed ID: 37190803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motor disorders related to oxaliplatin-induced peripheral neuropathy: long-term severity and impact on quality of life.
    Balayssac D; Kerckhove N; Selvy M; Pereira B; Gonneau C; Pétorin C; Vimal-Baguet A; Melnikov S; Kullab S; Hebbar M; Bouché O; Slimano F; Bourgeois V; Lebrun-Ly V; Thuillier F; Mazard T; Tavan D; Benmammar KE; Monange B; Ramdani M; Péré-Vergé D; Huet-Penz F; Bedjaoui A; Genty F; Leyronnas C; Pezet D; Martin V
    Support Care Cancer; 2024 Jun; 32(7):427. PubMed ID: 38869647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The analgesic effect of orexin-A in a murine model of chemotherapy-induced neuropathic pain.
    Toyama S; Shimoyama N; Shimoyama M
    Neuropeptides; 2017 Feb; 61():95-100. PubMed ID: 28041630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manganese- and Platinum-Driven Oxidative and Nitrosative Stress in Oxaliplatin-Associated CIPN with Special Reference to Ca
    Karlsson JOG; Jynge P
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Searching for analgesic drug candidates alleviating oxaliplatin-induced cold hypersensitivity in mice.
    Sałat K; Furgała A; Malikowska-Racia N
    Chem Biol Drug Des; 2019 Jun; 93(6):1061-1072. PubMed ID: 30900821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of clinical and patient factors with chemotherapy-induced peripheral neuropathy (CIPN) in colorectal cancer: secondary analysis of the SCOT trial.
    Lemanska A; Harkin A; Iveson T; Kelly C; Saunders M; Faithfull S
    ESMO Open; 2023 Dec; 8(6):102063. PubMed ID: 37988949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemoglobin, Body Mass Index, and Age as Risk Factors for Paclitaxel- and Oxaliplatin-Induced Peripheral Neuropathy.
    Mizrahi D; Park SB; Li T; Timmins HC; Trinh T; Au K; Battaglini E; Wyld D; Henderson RD; Grimison P; Ke H; Geelan-Small P; Marker J; Wall B; Goldstein D
    JAMA Netw Open; 2021 Feb; 4(2):e2036695. PubMed ID: 33587134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxaliplatin- and docetaxel-induced polyneuropathy: clinical and neurophysiological characteristics.
    Bennedsgaard K; Ventzel L; Andersen NT; Themistocleous AC; Bennett DL; Jensen TS; Tankisi H; Finnerup NB
    J Peripher Nerv Syst; 2020 Dec; 25(4):377-387. PubMed ID: 32902058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioenergetic deficits in peripheral nerve sensory axons during chemotherapy-induced neuropathic pain resulting from peroxynitrite-mediated post-translational nitration of mitochondrial superoxide dismutase.
    Janes K; Doyle T; Bryant L; Esposito E; Cuzzocrea S; Ryerse J; Bennett GJ; Salvemini D
    Pain; 2013 Nov; 154(11):2432-2440. PubMed ID: 23891899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Mitochondrial Mechanism in Chemotherapy-Induced Peripheral Neuropathy.
    Waseem M; Kaushik P; Tabassum H; Parvez S
    Curr Drug Metab; 2018; 19(1):47-54. PubMed ID: 29219049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of chemotherapy-induced peripheral neuropathy: A review of recent findings.
    Ibrahim EY; Ehrlich BE
    Crit Rev Oncol Hematol; 2020 Jan; 145():102831. PubMed ID: 31783290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of pattern recognition receptors in chemotherapy-induced neuropathic pain.
    Araldi D; Khomula EV; Bonet IJM; Bogen O; Green PG; Levine JD
    Brain; 2024 Mar; 147(3):1025-1042. PubMed ID: 37787114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High concentration of topical amitriptyline for treating chemotherapy-induced neuropathies.
    Rossignol J; Cozzi B; Liebaert F; Hatton S; Viallard ML; Hermine O; Greco C
    Support Care Cancer; 2019 Aug; 27(8):3053-3059. PubMed ID: 30607681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The preventive effect of sensorimotor- and vibration exercises on the onset of Oxaliplatin- or vinca-alkaloid induced peripheral neuropathies - STOP.
    Streckmann F; Balke M; Lehmann HC; Rustler V; Koliamitra C; Elter T; Hallek M; Leitzmann M; Steinmetz T; Heinen P; Baumann FT; Bloch W
    BMC Cancer; 2018 Jan; 18(1):62. PubMed ID: 29316888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.
    Kuriyama A; Endo K
    Support Care Cancer; 2018 Apr; 26(4):1051-1059. PubMed ID: 29280005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724).
    Albany C; Dockter T; Wolfe E; Le-Rademacher J; Wagner-Johnston N; Einhorn L; Lafky JM; Smith E; Pachman D; Staff N; Ma C; Loprinzi CL; Costello BA
    Support Care Cancer; 2021 Feb; 29(2):833-840. PubMed ID: 32500206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy-Induced Peripheral Neuropathy: Causative Agents, Preventative Strategies, and Treatment Approaches.
    Kachrani R; Santana A; Rogala B; Pawasauskas J
    J Pain Palliat Care Pharmacother; 2020 Sep; 34(3):141-152. PubMed ID: 32118502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.